.Attributes Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint calls for introduction of individuals along with MASLD and dimension of liver outcomes in cardio-- kidney-- metabolic trials, when records suggest mechanistically tenable benefits as well as clinical safety-- and summarizes factors to consider for test layout and also regulative commendation.